Adnan Nagrial
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 43
- Pancreatic and Hepatic Oncology Research 36
- Lung Cancer Research Studies 16
- Colorectal Cancer Treatments and Studies 11
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 28
-
- Lung Cancer Treatments and Mutations 21
- Immunology top 5%
- Surgery top 5%
-
- Neuroendocrine Tumor Research Advances 12
-
- Cancer Research and Treatments 9
- Co-authors
- Richard KeffordRichard A. ScolyerGeorgina V. LongAlexander M. MenziesMichael HughesLauren E. HayduGraham J. MannAnne Hamilton
- Journals
- Journal of Clinical Oncology (34 papers)Annals of Oncology (13 papers)Journal of Thoracic Oncology (5 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Adnan Nagrial
112 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Oncology 2.5k
- Cancer Research 453
- Pulmonary and Respiratory Medicine 698
- Immunology 439
- Surgery 837
Countries citing papers authored by Adnan Nagrial
This map shows the geographic impact of Adnan Nagrial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adnan Nagrial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adnan Nagrial more than expected).
Fields of papers citing papers by Adnan Nagrial
This network shows the impact of papers produced by Adnan Nagrial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adnan Nagrial. The network helps show where Adnan Nagrial may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adnan Nagrial, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 23 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 0 | |
| 15 | 2020 | 116 | |
| 16 | 2020 | 26 | |
| 17 | Preliminary Results of A Phase I/IIA Study of BMS-986156 (GLUCOCORTICOID-Induced Tumour Necrosis Factor Receptor-Related Gene [GITR] AGONIST), Alone and In Combination with Nivolumab in Patients with Advanced Solid Tumours | 2017 | 1 |
| 18 | The changing landscape of systemic therapy in advanced pancreatic cancer | 2016 | 1 |
| 19 | 2014 | 31 | |
| 20 | 2014 | 53 |
About Adnan Nagrial
Adnan Nagrial is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 116 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (43 papers), Pancreatic and Hepatic Oncology Research (36 papers), Cancer Genomics and Diagnostics (28 papers), Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (16 papers), Neuroendocrine Tumor Research Advances (12 papers), Colorectal Cancer Treatments and Studies (11 papers) and Cancer Research and Treatments (9 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (453 citations) and Pulmonary and Respiratory Medicine (698 citations). Adnan Nagrial has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Richard Kefford, Richard A. Scolyer, Georgina V. Long, Alexander M. Menzies, Michael Hughes, Lauren E. Haydu, Graham J. Mann, Anne Hamilton, John F. Thompson and Venessa Chin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancers and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.